Drug intelligence / Profile preview

64Cu-DDR2

Development stage
Preclinical
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

64Cu-DDR2 is a radiopharmaceutical imaging agent consisting of a molecule that targets discoidin domain receptor tyrosine kinase 2 (DDR2), labeled with the radioisotope copper-64. DDR2 is a receptor tyrosine kinase involved in cell adhesion, migration, and extracellular matrix remodeling. Overexpression or mutation of DDR2 has been implicated in various cancers and fibrotic diseases. The mechanism of action for 64Cu-DDR2 involves binding to the DDR2 protein on target cells, allowing for non-invasive positron emission tomography (PET) imaging to visualize and quantify DDR2 expression in vivo. This can aid in cancer diagnosis, patient stratification for targeted therapies, and monitoring disease progression or response to treatment.

Other names
copper-64 labeled DDR2 targeting agentcopper64 labeled DDR2 targeting agentcopper 64 labeled DDR2 targeting agent64Cu-labeled DDR2 probe
02

Targets

DDR2 (Discoidin domain receptor tyrosine kinase 2)

Beyond the preview

Go deeper on 64Cu-DDR2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 64Cu-DDR2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call